Valiant Laboratories Limited
NSE VALIANTLAB.NS
Valiant Laboratories Limited Gross Profit Margin for the year ending March 31, 2024: 7.58%
Valiant Laboratories Limited Gross Profit Margin is 7.58% for the year ending March 31, 2024, a -55.26% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Valiant Laboratories Limited Gross Profit Margin for the year ending March 31, 2023 was 16.95%, a -5.57% change year over year.
-
Valiant Laboratories Limited Gross Profit Margin for the year ending March 31, 2022 was 17.95%, a -43.94% change year over year.
-
Valiant Laboratories Limited Gross Profit Margin for the year ending March 31, 2021 was 32.02%.
Key data
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
Market news
Loading...
Don’t Miss A Beat
NSE: VALIANTLAB.NS
| CEO | Mr. Santosh Shantilal Vora |
| IPO Date | Oct. 6, 2023 |
| Location | India |
| Headquarters | 104, Udyog Kshetra |
| Employees | 77 |
| Sector | Industrials |
| Industries | |
Description
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.
Key trends
Past 5 years
StockViz Staff
February 2, 2025
Any question? Send us an email